Laraway Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
1,772
-24
| -1% | -$4.46K | 0.25% | 93 |
|
|
2025
Q1 | $376K | Buy |
1,796
+1
| +0.1% | +$210 | 0.3% | 80 |
|
|
2024
Q4 | $319K | Hold |
1,795
| – | – | 0.25% | 91 |
|
|
2024
Q3 | $355K | Hold |
1,795
| – | – | 0.28% | 84 |
|
|
2024
Q2 | $308K | Buy |
1,795
+1
| +0.1% | +$171 | 0.26% | 85 |
|
|
2024
Q1 | $327K | Hold |
1,794
| – | – | 0.29% | 86 |
|
|
2023
Q4 | $278K | Buy |
1,794
+1
| +0.1% | +$155 | 0.26% | 91 |
|
|
2023
Q3 | $267K | Sell |
1,793
-25
| -1% | -$3.73K | 0.28% | 85 |
|
|
2023
Q2 | $245K | Buy |
1,818
+1
| +0.1% | +$135 | 0.24% | 93 |
|
|
2023
Q1 | $290K | Hold |
1,817
| – | – | 0.29% | 89 |
|
|
2022
Q4 | $294K | Sell |
1,817
-33
| -2% | -$5.33K | 0.31% | 89 |
|
|
2022
Q3 | $248K | Hold |
1,850
| – | – | 0.28% | 94 |
|
|
2022
Q2 | $283K | Sell |
1,850
-50
| -3% | -$7.65K | 0.3% | 87 |
|
|
2022
Q1 | $307K | Buy |
1,900
+50
| +3% | +$8.08K | 0.28% | 91 |
|
|
2021
Q4 | $250K | Buy |
+1,850
| New | +$250K | 0.22% | 98 |
|